Testosterone Therapy, Prostate Safety, and Other Safety Issues
Testosterone replacement therapy has dramatically improved the quality of life of many men with late-onset hypogonadism. However, one concern that many doctors and patients have regarding this therapy is prostate safety. The main concern is the possible association with prostate cancer and minor concern with benign prostatic hyperplasia (BPH). As part of the natural history of the prostate, both the incidence and prevalence of both BPH and prostate cancer increase with aging men. In the natural scheme of things, testosterone level decreases with age. We were taught at medical school that prostate cancer and BPH are androgen dependent, and many doctors have great trepidation in giving the highly effective testosterone replacement therapy as a result of this. However, the current body of evidence generally sees no harm to the prostate in giving testosterone replacement therapy. There is no conclusive evidence (Roddam et al. 2008; Carpenter et al. 2008) that testosterone therapy increases the risk of prostate cancer or BPH.
KeywordsProstate Cancer Obstructive Sleep Apnea Benign Prostatic Hyperplasia Lower Urinary Tract Symptom International Prostate Symptom Score
- Huggins C, Hodges CV. Studies on prostatic cancer, I: the effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res. 1941;1:293–7.Google Scholar